DIN 02473224 — KADCYLA 160 MG
KADCYLA is a powder for solution of Trastuzumab Emtansine marketed by HOFFMANN-LA ROCHE LIMITED. The full Trastuzumab Emtansine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02473224
- Brand name
- KADCYLA
- Active ingredient
- Trastuzumab Emtansine
- Strength
- 160 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- HOFFMANN-LA ROCHE LIMITED
- Health Canada status
- MARKETED
- Drug class
- HER2-targeted antibody-drug conjugate (ADC) with a microtubule inhibitor payload
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Trastuzumab Emtansine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02412365 | KADCYLA | 100 MG | POWDER FOR SOLUTION | HOFFMANN-LA ROCHE LIMITED | MARKETED |